DEXTER SUSAN (Chief Technical Officer) received a stock award from SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/15/2025ACC: 0001641172-25-019779
Officer· Chief Technical Officer
Since Apr 2020
+8K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8K
Price / share
—
Trade value
—
% of position
486.9%
7/11/2025
1.64K→9.64K
Total
Net shares
+8K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/11/2025 | A · Award | +8K | — | — | 486.9% | 1.64K | 9.64K |
| Total | +8K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported